OraSure Technologies | OSUR - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Agilent USD 25M 2M 2025-12
AngioDynamics USD 100K 134K 2025-02
Becton, Dickinson and Co. USD 153M 2M 2025-12
Bio Techne USD 2.18M 173K 2025-06
Bio-Rad Laboratories USD 12.3M 100K 2025-09
Bruker USD 20M 4.3M 2025-09
Cerus USD 2.33M 96K 2024-06
Charles River Laboratories USD 23.78M 1.63M 2025-12
Danaher USD 55M 12M 2025-12
Dentsply International USD 22M 1000K 2025-12
Dexcom USD 4.7M 0 2025-09
Exact Sciences USD 9.79M 46K 2025-09
Hologic USD 27.6M 1000K 2025-12
Illumina USD 25M 0 2025-09
Integra LifeSciences USD 23.67M 953K 2025-12
Intuitive Surgical USD 19.35B 811.4M 2025-09
IQVIA Holdings USD 193M 4M 2025-12
Mesa Laboratories USD 3.02M 180K 2024-09
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 800K 100K 2025-03
OraSure Technologies 2.91M 130K 2024-12
Quidel USD 5.68B 5.63B 2025-09
Repligen USD 5.5M 81K 2025-12
Revvity USD 23.51M 742K 2025-12
STAAR Surgical USD 800K 799K 2025-09
Thermo Fisher Scientific USD 365M 18M 2025-12
Trinity Biotech USD 3.33M 50K 2025-09
Waters USD 8.62M 18.02M 2025-12